首页> 外文OA文献 >Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia lymphoma study

【2h】

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia lymphoma study

机译：多重复发B细胞急性淋巴细胞白血病患儿的结果：儿童白血病与淋巴瘤研究的治疗进展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Weili Sun; Jemily Malvar; Richard Sposto; Anupam Verma; Jennifer J. Wilkes; Robyn Dennis; Kenneth Heym; Theodore W. Laetsch; Melissa Widener; Susan R Rheingold; Javier Oesterheld; Nobuko Hijiya; Maria Luisa Sulis; Van Huynh; Andrew E. Place; Henrique Bittencourt; Raymond Hutchinson; Yoav Messinger; Bill Chang; Yousif Matloub; David S. Ziegler; Rebecca Gardner; Todd Cooper; Francesco Ceppi; Michelle Hermiston; Luciano Dalla-Pozza; Kirk R. Schultz; Paul Gaynon; Alan S. Wayne; James A. Whitlock;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase i study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium [J] . RaetzE.A., MorrisonD., Romanos-SirakisE., Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology . 2014,第6期

机译：EZN-3042的一项i期研究，一种新型的survivin信使核糖核酸（mRNA）拮抗剂，与化疗联合用于儿童复发性急性淋巴细胞白血病（ALL）：儿童白血病和淋巴瘤（TACL）的治疗进展报告财团
2. Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium. [J] . Messinger Y, Gaynon P, Raetz E, Pediatric blood & cancer . 2010,第2期

机译：硼替佐米联合化学疗法治疗儿童复发性儿童急性淋巴细胞白血病（ALL）的I期研究：儿童白血病（TACL）联合体治疗进展的报告。
3. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. [J] . Ko RH, Ji L, Barnette Journal of Clinical Oncology . 2010,第4期

机译：治疗复发性或难治性急性淋巴细胞白血病的患者的结果：儿童白血病协会的治疗进展。
4. Improved Treatment Outcome of Childhood Acute Lymphoblastic Leukemia [C] . . 2006

机译：改善儿童急性淋巴细胞白血病的治疗结果
5. Mechanisms and Therapeutic Targeting of NT5C2 Mutations in Relapsed Acute Lymphoblastic Leukemia [D] . Chelsea Dieck. 2019

机译：复发性急性淋巴细胞白血病中NT5C2突变的机制和治疗靶点
6. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia lymphoma study [O] . Weili Sun, Jemily Malvar, Richard Sposto, -1

机译：儿童多发性B细胞急性淋巴细胞白血病复发的结果：儿童白血病和淋巴瘤研究的治疗进展
7. Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium [O] . Yoav Messinger, Paul Gaynon, Elizabeth Raetz, 2010

机译：Ⅰ期博尔特佐米与复发儿童急性淋巴细胞白血病儿童联合化疗（全部）：儿童白血病（TACL）联盟的治疗进展报告

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia lymphoma study

著录项

相似文献

相关主题

期刊订阅